loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Abschluss nicht-exkl. AM-Rabattvereinbarungen nach § 130a Abs. 8 SGB V zum Wirkstoff Epoetin alfa (gentechnisch hergestelltes humanes Erythropoetin, Einschränkung auf Pkg. mit Dosierungen bis 10T I.E.

World Biggest Tenders Source

This tender with title Abschluss nicht-exkl. AM-Rabattvereinbarungen nach § 130a Abs. 8 SGB V zum Wirkstoff Epoetin alfa (gentechnisch hergestelltes humanes Erythropoetin, Einschränkung auf Pkg. mit Dosierungen bis 10T I.E. -- Pharmaceutical products has been published on Bidding Source portal dated 18 Oct 2021 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

Pharmaceutical products

General Information

Germany

Abschluss nicht-exkl. AM-Rabattvereinbarungen nach § 130a Abs. 8 SGB V zum Wirkstoff Epoetin alfa (gentechnisch hergestelltes humanes Erythropoetin, Einschränkung auf Pkg. mit Dosierungen bis 10T I.E.
Pharmaceutical products
Invitation for Bids
2021/S 201-522234
Germany
Germany-Erfurt
18 Oct 2021
31 Jul 2022
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

410634 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient granisetron (excluding Dafo. PFT), ATC A04AA02 fd Z. 01.08.2026 - 31.07.2028 (plus option for 1x12 months) Germany 410962 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient varenicline, ATC N07BA03, for the period 01.08.2026 - 31.07.2028 (plus extension option of 1 x 12 months) Germany 413427 - Germany – Pharmaceutical products – Open house drug discount contracts for the active ingredient chlorthalidone, ATC C03BA04 Germany 410682 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient nifedipine, ATC C08CA05, for the period 01.08.2026 - 31.07.2028 (plus extension option of 1 x 12 months) Germany 410903 - Germany – Pharmaceutical products – Open house drug discount contracts for the active ingredient alitretinoin, ATC D11AH04 Germany 411639 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient budesonide (brand name Kinpeygo and interchangeable medicinal products), ATC A07EA06 for the period 01.08.2026 - 31.07.2028 Germany 410373 - Germany – Pharmaceutical products – Open house drug discount contracts for the active ingredient colistin, ATC J01XB01 Germany 411195 - Germany – Pharmaceutical products – Open house drug discount contracts for the active ingredient ustekinumab, ATC L04AC05 Germany 411617 - Germany – Pharmaceutical products – Open house drug discount contracts for the active ingredient lisdexamfetamine, without hard capsules in pack size 30 pieces, ATC N06BA12 Germany 410478 - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient abaloparatide, ATC H05AA04, for the period 01.08.2026 - 31.07.2028 Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans